Teva Canada Secures Salbutamol Inhalers
Teva Canada Secures Salbutamol Inhalers from its Global Supply Chain to Mitigate Shortage in Canadian Market
Teva Canada to be first company to import emergency supply of salbutamol inhalers -
providing access to critically needed medication for Canadian patients
Toronto, Ontario (May 19, 2020) – Teva Canada announced today it has secured an emergency supply of PrSalamol CFC-Free Inhaler - 100 microgram Pressurised Inhalation Suspension (Salbutamol Sulfate) 200 dose through its global supply chain (Teva UK Ltd.) to alleviate critical shortages in the Canadian market.
Read Full Press Release